https://adisinsight.springer.com/drugsafety/803043858?error=cookies_not_supported&code=d3bc2f2e-7699-4ff7-9478-0640a8ac3dc5
Ibandronic acid - AdisInsight
A 65-year-old woman developed bilateral simultaneous femoral diaphyseal fractures during treatment with ibandronic acid for osteoporosis.The woman had been
ibandronic acidadisinsight
https://adisinsight.springer.com/drugsafety/803344697?error=cookies_not_supported&code=3e5cfd5d-69b7-47ea-a852-0936d4ed52e6
Ibandronic-acid - AdisInsight
A preliminary data of 190 patients conducted between February 2017 to January 2018, described a patient [age and sex not stated], who developed atypical
ibandronic acidadisinsight
https://adisinsight.springer.com/drugsafety/803205409?error=cookies_not_supported&code=88df77a0-7328-4df6-9232-0c2d3f15fc94
Alendronic acid/ibandronic acid/zoledronic acid - AdisInsight
A 68-year-old woman developed atypical femoral fracture during treatment with alendronic acid, ibandronic acid and zoledronic acid [route, dosage and time to
acidadisinsight
https://adisinsight.springer.com/drugsafety/803925341?error=cookies_not_supported&code=d63742a6-56f2-4a41-9f76-1c6757de29d0
Ibandronic acid - AdisInsight
An 86-year-old woman with a history of bilateral hip and knee arthritis and osteoporosis developed an atypical periprosthetic femoral fracture (APFF) associated
ibandronic acidadisinsight